Scope Fluidics S.A.
Biotechnology firm that incubates and sells microfluidic diagnostic projects.
SCP | WAR
Overview
Corporate Details
- ISIN(s):
- PLSCPFL00018
- LEI:
- 259400EUNFX4E2BEHU15
- Country:
- Poland
- Address:
- WARSZAWA OGRODOWA 58, 00-876 WARSZAWA
- Website:
- https://scopefluidics.com/
Description
Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-28 08:01 |
Jednostkowe sprawozdanie finansowe Scope Fluidics S.A.
|
Polish | XML • 5.2 MB | ||
| 2025-04-28 08:01 |
Skonsolidowane sprawozdanie finansowe Grupy Kapitałowej Scope Fluidics S.A.
|
Polish | XML • 327.9 KB | ||
| 2025-04-28 08:01 |
Skonsolidowane sprawozdanie finansowe Grupy Kapitałowej Scope Fluidics S.A.
|
Polish | ZIP • 1.5 MB | ||
| 2025-04-25 16:16 |
Zmiana terminu publikacji raportu rocznego - Content (PL)
|
Polish | HTML • 530 bytes | ||
| 2025-04-23 10:01 |
Decyzja Zarządu dotycząca wniosku do ZWZ dotyczącego podziału zysku za 2024 rok…
|
Polish | HTML • 3.1 KB | ||
| 2025-04-03 14:43 |
Decyzja Zarządu dotycząca procesu certyfikacji FDA dla systemu BACTEROMIC - Con…
|
Polish | HTML • 3.3 KB | ||
| 2025-02-28 17:09 |
Rozszerzenie współpracy z BIT w ramach projektu BACTEROMIC - Content (PL)
|
Polish | HTML • 2.3 KB | ||
| 2025-02-28 17:09 |
Rozszerzenie współpracy z BIT w ramach projektu BACTEROMIC
|
Polish | HTML • 2.2 KB | ||
| 2025-02-14 15:14 |
Realizacja pierwszego Celu Strategicznego - Content (PL)
|
Polish | HTML • 1.8 KB | ||
| 2025-02-14 15:14 |
Realizacja pierwszego Celu Strategicznego
|
Polish | HTML • 1.7 KB | ||
| 2025-01-24 17:13 |
Harmonogram publikacji raportów okresowych w 2025 roku - Content (PL)
|
Polish | HTML • 1.3 KB | ||
| 2025-01-08 13:36 |
Podsumowanie wyników Early Access Program - Content (PL)
|
Polish | HTML • 4.9 KB | ||
| 2025-01-08 13:23 |
Wyniki pierwszej fazy prac nad oprogramowaniem do "fast detection" - Content (P…
|
Polish | HTML • 3.1 KB | ||
| 2024-11-29 08:39 |
Skonsolidowany raport GK Scope Fluidics SA za III kwartał 2024 r.
|
Polish | PDF • 1.1 MB | ||
| 2024-11-28 17:50 |
Zakwalifikowanie projektu DSC027 do rozwoju w ramach spółki celowej - Content (…
|
Polish | HTML • 6.5 KB |
Automate Your Workflow. Get a real-time feed of all Scope Fluidics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Scope Fluidics S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Scope Fluidics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
